MDGL logo

Madrigal Pharmaceuticals, Inc. (MDGL) Return On Equity

Annual ROE:

-80.35%+43.63%(+35.19%)
December 31, 2024

Summary

  • As of today, MDGL annual return on equity is -80.35%, with the most recent change of +43.63% (+35.19%) on December 31, 2024.
  • During the last 3 years, MDGL annual ROE has risen by +30.57% (+27.56%).
  • MDGL annual ROE is now -125.31% below its all-time high of 317.48%, reached on December 31, 2009.

Performance

1-Year Change

+35.19%

3-Year Change

+27.56%

5-Year Change

-327.62%

15-Year Change

-182.03%

MDGL ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

34.89%
MDGL annual return on equity is higher than 34.89% of companies in Healthcare sector

Range

All-Time High

317.48%
MDGL annual return on equity is currently -125.31% below its historical high of 317.48%

3-Year Low

-150.12%
MDGL annual return on equity is currently +46.48% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
MDGL previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
MDGL next annual earnings announcement has not yet been scheduled

OtherMDGLprofitability metrics

Annual Revenue

$180.13M
MDGL annual revenue is $180.13 million

Annual Net Income

-$465.89M
MDGL annual net profit is -$465.89 million

Annual EPS

-$21.90
MDGL annual earnings per share is -$21.90

Annual ROA

-55.37%
MDGL annual return on assets is -55.37%

Quarterly ROE:

-37.14%+12.43%(+25.08%)
June 30, 2025

Summary

  • As of today, MDGL quarterly return on equity is -37.14%, with the most recent change of +12.43% (+25.08%) on June 30, 2025.
  • Over the past year, MDGL quarterly ROE has increased by +76.85% (+67.42%).
  • MDGL quarterly ROE is now -101.05% below its all-time high of 3532.29%, reached on March 31, 2010.

Performance

3-Month Change

+25.08%

1-Year Change

+67.42%

3-Year Change

+72.98%

5-Year Change

-12.92%

MDGL Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

51.34%
MDGL quarterly return on equity is higher than 51.34% of companies in Healthcare sector

Range

All-Time High

3532.29%
MDGL quarterly return on equity is currently -101.05% below its historical high of 3532.29%

3-Year Low

-358.86%
MDGL quarterly return on equity is currently +89.65% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
MDGL previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 30, 2025
MDGL next earnings announcement is scheduled for Oct 30, 2025

OtherMDGLprofitability metrics

Quarterly Revenue

$212.80M
MDGL quarterly revenue is $212.80 million

Quarterly Net Income

-$42.28M
MDGL quarterly net profit is -$42.28 million

Quarterly EPS

-$1.90
MDGL quarterly earnings per share is -$1.90

Quarterly ROA

-26.96%
MDGL quarterly return on assets is -26.96%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

-80.35%
MDGL annual return on equity is -80.35%

Annual Net Income

-$465.89M
MDGL annual net profit is -$465.89 million

Annual Shareholders Equity

$754.38M
MDGL annual stockholders equity is $754.38 million

MDGL ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+35.2%+67.4%
3Y3 Years+27.6%+73.0%
5Y5 Years-327.6%-12.9%

MDGL ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+46.5%at high+89.7%
5Y5-Year-327.6%+46.5%at high+89.7%
All-TimeAll-Time-125.3%+67.6%-101.0%+97.3%

MDGL ROE History

DateAnnualQuarterly
Jun 2025
-
-37.14%(+25.1%)
Mar 2025
-
-49.57%(+22.4%)
Dec 2024
-80.35%(+35.2%)
-63.91%(+28.2%)
Sep 2024
-
-89.04%(+21.9%)
Jun 2024
-
-113.99%(+21.4%)
Mar 2024
-
-145.00%(+31.8%)
Dec 2023
-123.98%(+17.4%)
-212.62%(+40.8%)
Sep 2023
-
-358.86%(-18.7%)
Jun 2023
-
-302.44%(-12.9%)
Mar 2023
-
-267.87%(-14.9%)
Dec 2022
-150.12%(-35.3%)
-233.13%(-14.2%)
Sep 2022
-
-204.19%(-48.6%)
Jun 2022
-
-137.44%(-23.4%)
Mar 2022
-
-111.39%(-10.7%)
Dec 2021
-110.92%(-80.0%)
-100.59%(-10.3%)
Sep 2021
-
-91.23%(-10.7%)
Jun 2021
-
-82.38%(-14.4%)
Mar 2021
-
-71.99%(-19.2%)
Dec 2020
-61.61%(-227.9%)
-60.38%(-32.5%)
Sep 2020
-
-45.56%(-38.5%)
Jun 2020
-
-32.89%(-35.8%)
Mar 2020
-
-24.22%(-30.4%)
Dec 2019
-18.79%(-88.8%)
-18.58%(-27.7%)
Sep 2019
-
-14.55%(-26.0%)
Jun 2019
-
-11.55%(-16.3%)
Mar 2019
-
-9.93%(-9.2%)
Dec 2018
-9.95%(+65.1%)
-9.09%(+15.6%)
Sep 2018
-
-10.77%(+30.1%)
Jun 2018
-
-15.41%(+50.1%)
Mar 2018
-
-30.91%(+26.8%)
Dec 2017
-28.49%(+60.7%)
-42.21%(+37.8%)
Sep 2017
-
-67.87%(+20.5%)
Jun 2017
-
-85.38%(-8.2%)
Mar 2017
-
-78.91%(+33.6%)
Dec 2016
-72.47%(+14.1%)
-118.87%(-56.3%)
Sep 2016
-
-76.03%(-205.7%)
Jun 2016
-
-24.87%(+66.3%)
Mar 2016
-
-73.71%(+36.0%)
Dec 2015
-84.39%(+44.1%)
-115.25%(-19.3%)
Sep 2015
-
-96.59%(+19.2%)
Jun 2015
-
-119.57%(+11.8%)
Mar 2015
-
-135.59%(+2.4%)
DateAnnualQuarterly
Dec 2014
-150.86%(-3.8%)
-138.89%(+19.8%)
Sep 2014
-
-173.25%(+20.8%)
Jun 2014
-
-218.87%(+8.7%)
Mar 2014
-
-239.79%(-22.7%)
Dec 2013
-145.29%(-3.9%)
-195.38%(+0.7%)
Sep 2013
-
-196.70%(-12.8%)
Jun 2013
-
-174.36%(-11.1%)
Mar 2013
-
-156.97%(+11.9%)
Dec 2012
-139.78%(+43.6%)
-178.11%(+19.1%)
Sep 2012
-
-220.27%(-7.8%)
Jun 2012
-
-204.37%(+1.7%)
Mar 2012
-
-208.01%(+1.3%)
Dec 2011
-247.72%(-60.0%)
-210.82%(-14.9%)
Sep 2011
-
-183.52%(-15.1%)
Jun 2011
-
-159.45%(-14.3%)
Mar 2011
-
-139.54%(-14.4%)
Dec 2010
-154.85%(-148.8%)
-122.00%(-10.0%)
Sep 2010
-
-110.87%(-111.0%)
Jun 2010
-
1005.82%(-71.5%)
Mar 2010
-
3532.29%(+1372.4%)
Dec 2009
317.48%(+101.5%)
-277.61%(-128.0%)
Sep 2009
-
-121.77%(-195.1%)
Jun 2009
-
128.11%(-39.9%)
Mar 2009
-
213.20%(-46.5%)
Dec 2008
157.54%(+180.6%)
398.84%(+129.0%)
Sep 2008
-
-1375.78%(-354.8%)
Jun 2008
-
-302.47%(-83.6%)
Mar 2008
-
-164.70%(+4.4%)
Dec 2007
-195.46%(-57.9%)
-172.34%(-20.1%)
Sep 2007
-
-143.48%(-3.4%)
Jun 2007
-
-138.70%(+4.0%)
Mar 2007
-
-144.55%(-4.1%)
Dec 2006
-123.76%(-53.1%)
-138.81%(-27.9%)
Sep 2006
-
-108.50%(-84.5%)
Jun 2006
-
-58.80%(-90.4%)
Mar 2006
-
-30.89%(-28.2%)
Dec 2005
-80.81%(-71.4%)
-24.09%(-31.6%)
Mar 2005
-
-18.30%
Dec 2004
-47.15%(+8.6%)
-
Dec 2003
-51.61%(+55.5%)
-
Dec 2002
-116.06%(-736.2%)
-
Dec 2001
-13.88%
-

FAQ

  • What is Madrigal Pharmaceuticals, Inc. annual return on equity?
  • What is the all-time high annual ROE for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. annual ROE year-on-year change?
  • What is Madrigal Pharmaceuticals, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. quarterly ROE year-on-year change?

What is Madrigal Pharmaceuticals, Inc. annual return on equity?

The current annual ROE of MDGL is -80.35%

What is the all-time high annual ROE for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high annual return on equity is 317.48%

What is Madrigal Pharmaceuticals, Inc. annual ROE year-on-year change?

Over the past year, MDGL annual return on equity has changed by +43.63% (+35.19%)

What is Madrigal Pharmaceuticals, Inc. quarterly return on equity?

The current quarterly ROE of MDGL is -37.14%

What is the all-time high quarterly ROE for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high quarterly return on equity is 3532.29%

What is Madrigal Pharmaceuticals, Inc. quarterly ROE year-on-year change?

Over the past year, MDGL quarterly return on equity has changed by +76.85% (+67.42%)
On this page